Novartis Stock Guidance

NVSNYSE

$114.29

At close: May 2, 7:47 PM EDT

$114.78

0.490.43%

Pre-Market: May 2, 7:47 PM EDT

Q1 2025 Earnings were released on Tue Apr 29th, before the market open

The most recent conference call was at 8:00 AM, 6 days ago Click to view past webcast

Regulus Therapeutics (RGLS) announced it will be merged with Novartis (NVS) on Wednesday, April 30, 2025 for $800.0M paid in cash

Guidance

Novartis issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
Novartis AG (NVS) does not provide guidance data

There have been no specific sales or earnings guidance reported for Novartis in recent months.

Browse guidance and forecast on all stocks.